April 12, 2022 — Esaote S.p.A., a leading biomedical company in the diagnostic imaging sector – especially in the fields of ultrasound, magnetic resonance and information technology for healthcare – is celebrating 40 years in business with an international event.

Early-stage detection is key to the prevention of life-threatening diseases; however, limited access to data hinders the ability of radiology healthcare professionals to identify excess exposure to radiation in patients, which could result in both short and long-term health effects.

April 11, 2022 — Mount Sinai researchers have developed a novel method to identify aggressive early-stage lung cancers and target drugs known as aurora kinase inhibitors to tumors that are especially likely to respond to them.

April 11, 2022 — Nano-X Imaging Ltd, an innovative medical imaging technology company, announced that it has opened its new semiconductor chip fabrication plant in South Korea.

April 11, 2022 — A novel nuclear medicine combination therapy has been proven safe and effective in men with heavily pre-treated metastatic castration-resistant prostate cancer (mCRPC).

April 11, 2022 — Radiation to the heart during treatment for locally advanced lung cancer is associated with an increased risk of major adverse cardiac events within the first two years following treatment. The higher the cardiac dose exposure, the higher the risk of a cardiac event.

April 11, 2022 — RSIP Vision, an experienced leader in driving innovation for medical imaging through advanced artificial intelligence (AI) and computer vision solutions, announced a new tool for

April 8, 2022 — Toronto-based Molli Surgical is gaining momentum, providing its patient-first solution to University Health Network’s (UHN) Sprott Department of Surgery. Molli Surgical’s Canadian-designed, wire-free and radiation-free marker technology for localizing lesions for breast cancer surgery will improve patient and physician comfort and confidence.

April 8, 2022 — The Centers for Medicare & Medicaid Services (CMS) released a national policy for coverage of aducanumab (brand name Aduhelm) and any future monoclonal antibodies directed against amyloid approved by the FDA with an indication for use in treating Alzheimer’s disease.

April 8, 2022 — Elekta’s latest linear accelerator, Elekta Harmony, has won a 2022 Red Dot Award for product design. Harmony, which was granted CE mark and U.S.

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now